Summary
AddLife AB (publ) Class B (ALIFBs) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has AddLife AB (publ) Class B ever had a stock split?
AddLife AB (publ) Class B Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Fredrik Dalborg CEO | CBOE Exchange | SE0014401378 ISIN |
| Sweden Country | 2,322 Employees | 7 May 2026 Last Dividend | 27 May 2020 Last Split | - IPO Date |
Overview
AddLife AB (publ) is a distinguished company deeply rooted in providing high-quality products, equipment, and services to the healthcare industry, research institutions, academic environments, and the food and pharmaceutical sectors. Incepted in 1906 and headquartered in Stockholm, Sweden, AddLife AB boasts a rich heritage and a detailed understanding of the specific needs across various scientific and medical fields. With a broad international presence, the company is segmented into two main operational units: Labtech and Medtech, catering to a wide range of professional requirements through its extensive product portfolio and solutions designed to advance research, diagnostics, and patient care worldwide. The comprehensive geographic footprint of AddLife spans across Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, and other parts of Europe, ensuring a global impact on improving health and scientific outcomes.
Products and Services
- Labtech Division
The Labtech segment of AddLife AB stands as a foundation for diagnostic advancements and biomedical research, offering a vast array of laboratory equipment, plastic consumables, cell biology essentials, reagents, and various instruments. This division is pivotal in supporting researchers and healthcare providers with the necessary tools and materials to conduct in-depth studies, enhance laboratory productivity, and achieve accurate diagnostics, thereby facilitating the advancement of science and improvement of patient outcomes.
- Medtech Division
Within the Medtech segment, AddLife AB concentrates on the provision of medical devices crucial for a wide spectrum of healthcare procedures and patient care. The offerings encompass surgery instruments, thoracic medicine supports, neurology devices, wound care products, anaesthesia and intensive care equipment, tools for ear, nose, and throat (ENT) treatments, solutions for ostomies, and home healthcare. Additionally, it supplies assistive technology aimed at improving the quality of life for senior citizens and disabled children. By covering these critical areas, AddLife AB directly contributes to enhancing surgical outcomes, patient care, and the overall efficiency of medical and health support services.
